Stock listing
Geovax Labs, Inc.
Selected listing: E8LA · SWB · EUR · DE
Geovax Labs, Inc. (Stuttgart:E8LA), Health Technology. Latest release Oct 6, 2026: GeoVax to Highlight Next-Generation MVA Vaccine and Manufacturing Advances…
- Ticker
- Stuttgart:E8LA
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- Stuttgart
- Currency
- EUR
About Geovax Labs, Inc.
Geovax Labs, Inc. (ticker: GOVX) is a public company based in the United States, focusing on the development of innovative vaccines and immunotherapies. The company aims to leverage its proprietary technologies to create effective solutions for global health challenges.
Latest news from Geovax Labs, Inc.
GeoVax to Highlight Next-Generation MVA Vaccine and Manufacturing Advances at World Vaccine Congress Europe 2026
October 6, 2026
GeoVax Provides Nasdaq Listing Update and Reaffirms Focus on Advancing Strategic Priorities
September 10, 2026
GeoVax Advances GEO-MVA Toward Pivotal Phase 3 Study Implementation
August 25, 2026
GeoVax Chairman and CEO David Dodd to Participate in 2026 Georgia Life Sciences Summit
August 20, 2026
GeoVax Highlights Newly Published Independent Research Supporting Broader Filovirus Vaccine Strategies and Strategic Value of Its MVA-Based Vaccine Portfolio
August 3, 2026